Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secretoglobin family 2B member 3, pseudogene (SCGB2B3P) is a human gene annotated as a pseudogene, not predicted to encode a functional protein. It belongs to the secretoglobin (SCGB) family, which includes small secreted proteins with roles in inflammation, tissue repair, tumorigenesis, and other biological processes. However, as a pseudogene, SCGB2B3P does not produce an active protein and thus does not participate in these biological functions. It is cataloged in gene databases with aliases such as C2B and SCGB4A3P. There is no evidence of function, disease roles, drug interactions, or biomarker status for this gene. Secretoglobins are small, secreted proteins expressed in mammals, with some roles in inflammation and tissue repair. SCGB2B3P is specifically annotated as a pseudogene in humans, meaning it lacks coding potential for a functional protein. Pseudogenes like SCGB2B3P are not considered therapeutic targets, receptors, or functional enzymes, and do not have associated drugs, biomarkers, or safety concerns relevant to therapy. The SCGB superfamily and their nomenclature have been revised to ensure accuracy, and SCGB2B3P is consistently classified as a non-functional pseudogene. SCGB2B3P is not a true protein-coding target and is not involved in disease, drug action, or biomarker use; it is a pseudogene and should not be considered a molecular target for therapeutic or diagnostic development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secretoglobin family 2B member 3, pseudogene (SCGB2B3P).